4.7 Article

Baicalin increases VEGF expression and angiogenesis by activating the ERRa/PGC-1α pathway

Journal

CARDIOVASCULAR RESEARCH
Volume 89, Issue 2, Pages 426-435

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvq296

Keywords

Baicalin; VEGF; Angiogenesis; HIF-1 alpha; ERR alpha

Funding

  1. Stop Cancer Foundation
  2. Concern Foundation
  3. Markel Friedman Fund
  4. NIH [RO1 ES08258]

Ask authors/readers for more resources

Aims Baicalin is the major component found in Scutellaria baicalensis root, a widely used herb in traditional Chinese medicine. Although it has been used for thousands of years to treat stroke, the mechanisms of action of S. baicalensis have not been clearly elucidated. In this report, we studied the modulation of angiogenesis as one possible mechanism by investigating the effects of these agents on expression of vascular endothelial growth factor (VEGF), a critical factor for angiogenesis. Methods and results The effects of baicalin and an extract of S. baicalensis on VEGF expression were tested in several cell lines. Both agents induced VEGF expression in all cells without increasing expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha). The expression of reporter genes was also activated under the control of the VEGF promoter containing either a functional or a defective HIF response element (HRE). Only minimal effects were observed on reporter activation under the HRE promoter. Instead, both agents significantly induced oestrogen-related receptor (ERR alpha) expression as well as the activity of reporter genes under the control of ERR alpha-binding element. Their ability to induce VEGF expression was suppressed once ERR alpha expression was knocked down by siRNA or ERR alpha-binding sites were deleted in the VEGF promoter. We also found that both agents stimulated cell migration and vessel sprout formation from the aorta. Conclusion Our results implicate baicalin and S. baicalensis in angiogenesis by inducing VEGF expression through the activation of the ERR alpha pathway. These data may facilitate a better understanding of the potential health benefits of these agents in the treatment of cardiovascular diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available